Senate approves bill on drug regulation giving FDA new powers

With the bill's drug-import provision made moot, the Senate voted overwhelmingly to require the FDA to monitor drugs after they have gone to market and drugmakers to reveal trial data. The 93-1 vote sent the measure to the House where similar legislation is pending. The Senate version also would order changes in drug labels and advertising as well as support the FDA's new powers through additional user fees.

View Full Article in: · Washington Post (tiered subscription model), The · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA